Project Grant K01HL180816
- Federal Grant Award Summary The University of Arizona received a $1,476,174 Project Grant from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through May 31, 2029. The award funds basic research investigating the role of hepatocyte transmembrane protein 141 (TMEM141) in lipoprotein metabolism and atherosclerosis development. The project delivers scientific research outputs through the use of genetically...
- Federal Project Grant Award Summary The University of Arizona, operating as the Arizona Board of Regents, received a Project Grant award of $558,127 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2026 through July 31, 2033. The project, titled "Decoding the Enigma of Cardiac Arrhythmia and Mechanosensitivity," will deliver multidisciplinary research aimed at understanding small conductance...
- Grant Award Summary The University of Arizona received a $576,786 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 5, 2025, with completion targeted for August 31, 2028. This research initiative investigates protein translation mechanisms underlying oxidative stress response in heart failure, specifically examining the role of YTHD2 (a YTH domain-containing N6-methyladenosine binding...
- Federal Project Grant Award Summary Arizona State University received a $252,676 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with completion targeted for August 31, 2027. The award funds development and evaluation of the Computer Aided Exercise Stress ECG Reader (CAESAR), an artificial intelligence-driven diagnostic tool designed to improve the accuracy of exercise stress...
- Grant Award Summary The University of Arizona received a $1.57 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 5, 2026, with completion scheduled for February 28, 2028. The award funds research on ATF6 (Activating Transcription Factor 6) as a regulator of endoplasmic reticulum (ER) proteostasis in atrial myocytes. The project investigates how ATF6, an ER-localized transcription...
- Federal Project Grant Summary The University of Texas Rio Grande Valley received a $222,000 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through July 31, 2027. The grant funds research focused on analyzing 24-hour (24-H) blood pressure dysregulations using population-based and clinical cohort data to develop innovative metrics and methodologies for understanding blood...
- The University of Arizona received a $1.34 million Project Grant from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion targeted for June 30, 2029. This research initiative investigates the role of hexokinase 3 (HK3) in macrophage polarization and cardiac remodeling following myocardial infarction and ischemia/reperfusion injury. The project delivers fundamental mechanistic research using...
- Federal Project Grant Award Summary The University of Southern California received a $262,159 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 10, 2025, with completion targeted for August 31, 2027. The project will generate messenger RNA sequencing and genome-wide single nucleotide polymorphism array data from 400 Hispanic/Latino umbilical cord blood samples housed in the NHLBI BioLINCC...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1.62 million Project Grant from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 25, 2025, with completion targeted for June 30, 2027. The award funds research to identify circulating metabolic signatures and biologic pathways linking metabolic dysfunction and ectopic adiposity to cardiac dysfunction and heart failure...
- Federal Grant Award Summary Mayo Clinic Arizona, through funding from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), is conducting a four-year research project investigating the role of Programmed Cell Death 4 (PDCD4) in doxorubicin-induced cardiotoxicity. The $695,997 project grant, awarded August 18, 2025, and extending through May 31, 2029, focuses on understanding how PDCD4 functions as a cardioprotective molecule...
Federal Project Grant Summary The University of Arizona received a $140,400 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2026 through June 30, 2031. The grant funds "Corazón en Tus Manos," a culturally-tailored cardiovascular disease (CVD) risk-reduction intervention designed specifically for Mexican-origin adults with confirmed metabolic dysfunction-associated steatotic liver disease (MASLD). The project adapts "Su Corazón, Su Vida," an evidence-based, community health worker-led curriculum that incorporates stress-management techniques alongside CVD risk awareness education, healthy food choices promotion, and physical activity guidance. The intervention addresses a documented health disparity, as MASLD prevalence among Mexican-origin adults in Southern Arizona reaches approximately 50%—exceeding the national prevalence of 43%—and individuals with MASLD face a 64% increased risk of CVD, which remains the leading cause of death in the United States among this population. The project will examine the acceptability and feasibility of the adapted curriculum while supporting principal investigator Dr. Adriana Maldonado's career development as a CVD health disparities researcher. Deliverables include research findings on intervention outcomes and a comprehensive training plan designed to advance Dr. Maldonado's expertise in addressing health inequities affecting Hispanic populations. This funding supports the first phase of what is intended as a long-term research agenda to identify and address root causes of CVD disparities in underserved communities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $140.4k | 7/1/26 |